Sri Lanka to receive first batch of Covid-19 vaccines on Jan. 27 – President

Sri Lanka to receive first batch of Covid-19 vaccines on Jan. 27 – President

January 23, 2021   11:58 am

President Gotabaya Rajapaksa says the first batch of Oxford-AstraZeneca Covid-19 vaccines manufactured in India is expected to arrive in Sri Lanka on the 27th of January.

Accordingly, Sri Lanka will be receiving the 500,000 vials of doses with the first vaccine consignment.

The President’s remarks came during the ‘Gama Samaga Pilisandara’ programme held in Walallawita, Kalutara today (January 23).

He noted that Covid-19 jabs will be first administered to medical officers, Public Health Inspectors (PHIs) and other health sector workers who are on the front line of coronavirus outbreak in the country.

Officers of tri-forces who work closely with medical staff and people who are more vulnerable to virus infection will be given the jabs subsequently, the President added.


The National Medicines Regulatory Authority (NMRA) yesterday approved the emergency use of Oxford-AstraZeneca Covid-19 vaccines in Sri Lanka.

Indian High Commission in Colombo later said the Sri Lankan government has conveyed that approval was granted for the emergency use of COVISHIELD vaccines.

COVISHIELD is the local name for the Oxford-AstraZeneca vaccine developed in the United Kingdom.

The shots developed by UK-based drugmaker AstraZeneca and Oxford University are being manufactured at India’s Serum Institute – world’s largest vaccine manufacturer.

The vaccine, which is known as COVISHIELD, is developed from a weakened version of a common cold virus (known as an adenovirus) from chimpanzees.

It is administered in two shots – the second dose must be taken four to six weeks following the first.

Unlike the Pfizer-BioNTech jabs, which require 70C temperature for storage, COVISHIELD can be safely stored at temperatures of 2C to 8C, which is about the same as a domestic refrigerator.

India on Wednesday (January 20) began supplying Covid-19 vaccines to six neighbouring and key partner countries. Thereby, Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles became the first recipients of India-manufactured vaccines.

The vaccines supplied to neighbouring countries are sent as grants and India’s External Affairs Ministry said the vaccines were not part of COVAX – the United Nations-backed global effort aimed at lower-income nations to obtain the jabs.

Disclaimer: All the comments will be moderated by the AD editorial. Abstain from posting comments that are obscene, defamatory or slanderous. Please avoid outside hyperlinks inside the comment and avoid typing all capitalized comments. Help us delete comments that do not follow these guidelines by flagging them(mouse over a comment and click the flag icon on the right side). Do use these forums to voice your opinions and create healthy discourse.

Most Viewed Video Stories

Trump Tariff: Exports volume will reduce but real challenge is rates of Sri Lanka's competitors – expert (English)

Trump Tariff: Exports volume will reduce but real challenge is rates of Sri Lanka's competitors – expert (English)

Sri Lanka govt not considering retaliatory measures over Trump's tariff - Presidential Advisor (English)

Sri Lanka's opposition reacts to Trump's announcement on 30% trade tariff (English)

Ceylon Chamber urges continued engagement to secure further US tariff reduction (English)

Trump slashes tariff rate on Sri Lanka to 30% from 44% - But govt, private sector seeks further reduction

LIVE🔴Ada Derana Prime Time News Bulletin 6.55 pm

LIVE🔴 Ada Derana Lunch Time News Bulletin 12.00 pm

Sri Lanka gradually moving toward 5% inflation in coming quarters – CBSL Governor (English)